Mirror vs Virtual Reality Therapy for Upper Extremity Function in Hemiplegic Patients
Launched by ISTINYE UNIVERSITY · Jun 10, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two innovative therapies—mirror therapy and virtual reality (VR) therapy—to see which one helps improve arm and hand function in patients who have hemiplegia (weakness on one side of the body) after a stroke. Hemiplegia can make daily activities challenging and affect a person's quality of life. The study involves 42 participants aged 18 to 75 who are at least six months post-stroke and need help with using their affected arm. Participants will be randomly assigned to either therapy and will be evaluated on various aspects, like how well they can move their arms, how stiff their muscles are, and how well they can perform everyday tasks.
To join the study, individuals must have had a stroke between six to twelve months ago, show a certain level of arm function, and have the ability to understand the therapy methods. Those with severe muscle stiffness or other neurological conditions that could interfere with the study will not be eligible. Participants can expect to engage in either mirror therapy, which uses a reflective surface to create the illusion of movement, or VR therapy, which uses interactive games and simulations. This trial aims to provide valuable insights into effective rehabilitation methods for improving motor skills after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hemiplegic patients in need of upper extremity rehabilitation.
- • Having had a stroke 6 to 12 months prior to the study.
- • Being at least Stage 3 for the upper extremity according to the Brunnstrom motor recovery stages.
- • Age range: between 18 and 75 years.
- • Individuals who volunteer to participate in the study.
- • Individuals who are cognitively suitable for mirror therapy and virtual reality applications (a score of at least 24 on the Mini Mental State Examination)
- Exclusion Criteria:
- • Patients with severe spasticity (score ≥ 3 on the Modified Ashworth Scale)
- • Individuals with secondary neurological conditions (e.g., Parkinson's disease, multiple sclerosis).
- • Individuals diagnosed with vestibular dysfunction (as virtual reality equipment may cause issues like nausea or dizziness).
- • Individuals with communication issues, such as hearing or vision loss.
About Istinye University
Istinye University is a leading academic institution committed to advancing medical research and education. With a strong emphasis on innovation and collaboration, the university actively engages in clinical trials that aim to enhance healthcare outcomes and contribute to scientific knowledge. Leveraging its state-of-the-art facilities and a team of experienced researchers and clinicians, Istinye University fosters a rigorous environment for conducting high-quality clinical studies across various medical disciplines. The institution is dedicated to ethical practices and patient safety, ensuring that all research initiatives align with the highest standards of integrity and scientific excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Gaziosmanpaşa, Turkey
Istanbul, , Turkey
Patients applied
Trial Officials
Çiçek Günday, Asst. Prof., Doctor of Physical Therapy
Principal Investigator
Istinye University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported